Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 474581 - 474600 out of 483426 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX08) lenvatinib (adm: O) | LENVIMA/8MG 30 DAY CARTON | 6 | Ex-factory price without vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | Eisai,Inc. |
| USA | (L01EX09) nintedanib (adm: O) | OFEV 100MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EX09) nintedanib (adm: O) | OFEV 100MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EX09) nintedanib (adm: O) | OFEV 150MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EX09) nintedanib (adm: O) | OFEV 150MG CAP | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 112 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX10) midostaurin (adm: O) | RYDAPT 25MG CAPSULE | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid, Acute;Mastocytosis | NovartisPharmaceuticalsCorporation |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 17.7MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX11) quizartinib | VANFLYTA 26.5MG TAB | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myeloid | DaiichiSankyo,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 100ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 2x50ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX12) larotrectinib (adm: O) | VITRAKVI 20MG/ML SOLN,ORAL | 100ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Abdominal Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
Pages
